Neurocrine Biosciences, Inc. (BIT:1NBIX)

Neurocrine Biosciences Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 5, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Cap	11,088	12,215	11,674	11,189	9,917	6,954
Market Cap Growth	0.23%	4.64%	4.33%	12.83%	42.60%	-9.81%
Enterprise Value	10,217	11,299	11,140	10,524	9,146	6,721
PE Ratio	27.20	30.37	41.49	53.34	76.56	92.58
Forward PE	15.40	15.87	18.15	21.34	22.53	24.55
PEG Ratio	-	0.75	0.31	0.65	0.66	0.37
PS Ratio	4.55	4.96	5.76	6.89	7.74	7.13
PB Ratio	4.00	4.36	5.24	5.83	6.75	5.88
P/TBV Ratio	3.49	4.47	5.47	5.96	6.92	6.07
P/FCF Ratio	17.39	18.96	24.35	35.96	35.70	34.67
P/OCF Ratio	16.63	18.14	22.79	33.35	33.96	31.51
EV/Sales Ratio	4.14	4.59	5.50	6.48	7.14	6.89
EV/EBITDA Ratio	16.28	20.23	21.67	44.94	40.17	68.89
EV/EBIT Ratio	18.62	21.21	22.69	48.75	42.69	76.21
EV/FCF Ratio	16.02	17.54	23.24	33.83	32.92	33.51
Debt / Equity Ratio	0.13	0.13	0.18	0.12	0.05	0.32
Debt / EBITDA Ratio	0.64	0.64	0.76	1.57	0.99	3.88
Debt / FCF Ratio	0.56	0.56	0.82	1.19	0.81	1.89
Net Debt / Equity Ratio	-0.33	-0.33	-0.24	-0.27	-0.42	-0.20
Net Debt / EBITDA Ratio	-1.64	-1.64	-1.04	-2.22	-2.74	-2.39
Net Debt / FCF Ratio	-1.42	-1.42	-1.11	-1.67	-2.25	-1.16
Asset Turnover	0.69	0.69	0.68	0.67	0.67	0.60
Inventory Turnover	0.82	0.82	0.71	1.08	0.71	0.49
Quick Ratio	2.92	2.92	3.06	2.25	2.49	3.65
Current Ratio	3.39	3.39	3.40	2.45	2.70	3.96
Return on Equity (ROE)	16.38%	16.38%	14.16%	12.68%	10.03%	7.17%
Return on Assets (ROA)	10.06%	10.06%	11.50%	6.71%	8.10%	4.76%
Return on Invested Capital (ROIC)	18.04%	18.04%	20.28%	13.46%	16.60%	9.53%
Return on Capital Employed (ROCE)	17.44%	17.44%	19.65%	11.33%	13.62%	6.07%
Earnings Yield	3.68%	3.29%	2.41%	1.87%	1.31%	1.08%
FCF Yield	5.75%	5.27%	4.11%	2.78%	2.80%	2.88%
Buyback Yield / Dilution	0.27%	0.27%	1.31%	-0.50%	-0.39%	-0.34%

Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.